RMTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rockwell Medical Inc (RMTI) is not a good buy at the moment for a beginner investor with a long-term strategy. The company is facing significant financial challenges, with declining revenue, net income, and EPS. Additionally, technical indicators and options data do not suggest a strong upward trend or positive sentiment. The lack of positive news or catalysts further supports a cautious approach.
The MACD is negative and expanding downward (-0.012), indicating bearish momentum. RSI is at 37.82, which is neutral but leaning towards oversold territory. Moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 1.015), with resistance at R1: 1.152. Overall, the technical indicators suggest a weak trend with no strong buy signal.
No positive catalysts identified. No recent news or significant insider/hedge fund activity.
Financial performance is deteriorating significantly, with revenue, net income, and EPS all showing sharp declines in the latest quarter (2025/Q3). Technical indicators are weak, and the stock is in a bearish trend. No recent congress trading data or influential figure activity to support the stock.
In 2025/Q3, revenue dropped by -43.75% YoY to $15,927,000. Net income declined by -222.50% YoY to -$1,753,000. EPS fell by -225.00% YoY to -$0.05. Gross margin also decreased to 17.4%, down -21.02% YoY. These metrics indicate severe financial challenges.
No recent analyst ratings or price target changes available for evaluation.
